A detailed history of Gamble Jones Investment Counsel transactions in Pfizer Inc stock. As of the latest transaction made, Gamble Jones Investment Counsel holds 239,082 shares of PFE stock, worth $6.19 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares
239,082
Previous 244,307 2.14%
Holding current value
$6.19 Million
Previous $10.7 Million 14.63%
% of portfolio
0.92%
Previous 0.87%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $218,143 - $284,762
-5,225 Reduced 2.14%
239,082 $12.3 Million
Q3 2022

Nov 03, 2022

SELL
$43.76 - $53.42 $22,317 - $27,244
-510 Reduced 0.21%
244,307 $10.7 Million
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $223,669 - $265,202
-4,807 Reduced 1.93%
244,817 $12.8 Million
Q1 2022

May 02, 2022

SELL
$45.75 - $56.69 $68,853 - $85,318
-1,505 Reduced 0.6%
249,624 $12.9 Million
Q4 2021

Feb 09, 2022

SELL
$41.32 - $61.25 $69,954 - $103,696
-1,693 Reduced 0.67%
251,129 $14.8 Million
Q3 2021

Nov 09, 2021

SELL
$39.25 - $50.42 $53,183 - $68,319
-1,355 Reduced 0.53%
252,822 $10.9 Million
Q2 2021

Aug 06, 2021

SELL
$35.91 - $40.68 $59,215 - $67,081
-1,649 Reduced 0.64%
254,177 $9.95 Million
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $366,648 - $413,505
-10,948 Reduced 4.1%
255,826 $9.27 Million
Q4 2020

Feb 10, 2021

SELL
$33.47 - $42.56 $1.01 Million - $1.29 Million
-30,215 Reduced 10.17%
266,774 $9.82 Million
Q3 2020

Nov 10, 2020

BUY
$31.75 - $37.25 $186,499 - $218,806
5,874 Added 2.02%
296,989 $10.9 Million
Q2 2020

Aug 19, 2020

SELL
$30.12 - $36.54 $6,777 - $8,221
-225 Reduced 0.08%
291,115 $9.52 Million
Q1 2020

May 08, 2020

SELL
$27.03 - $38.62 $43,977 - $62,834
-1,627 Reduced 0.56%
291,340 $9.51 Million
Q4 2019

Feb 10, 2020

BUY
$32.92 - $37.36 $212,136 - $240,747
6,444 Added 2.25%
292,967 $11.5 Million
Q3 2019

Nov 04, 2019

SELL
$32.49 - $42.13 $274,832 - $356,377
-8,459 Reduced 2.87%
286,523 $10.3 Million
Q2 2019

Aug 20, 2019

SELL
$36.98 - $41.52 $216,961 - $243,597
-5,867 Reduced 1.95%
294,982 $12.8 Million
Q1 2019

May 02, 2019

SELL
$37.5 - $41.2 $42,825 - $47,050
-1,142 Reduced 0.38%
300,849 $12.8 Million
Q4 2018

Feb 04, 2019

SELL
$38.47 - $43.86 $80,902 - $92,237
-2,103 Reduced 0.69%
301,991 $13.2 Million
Q3 2018

Nov 06, 2018

SELL
$34.47 - $41.81 $374,723 - $454,516
-10,871 Reduced 3.45%
304,094 $13.4 Million
Q2 2018

Aug 03, 2018

SELL
$32.98 - $35.16 $7.14 Million - $7.61 Million
-216,474 Reduced 40.73%
314,965 $11.4 Million
Q1 2018

May 10, 2018

SELL
$31.91 - $37.02 $29,963 - $34,761
-939 Reduced 0.18%
531,439 $18.9 Million
Q4 2017

Feb 06, 2018

SELL
$33.26 - $35.29 $89,668 - $95,141
-2,696 Reduced 0.5%
532,378 $19.3 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $16.6 Million - $18.3 Million
535,074
535,074 $19.1 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Gamble Jones Investment Counsel Portfolio

Follow Gamble Jones Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamble Jones Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Gamble Jones Investment Counsel with notifications on news.